PIIIP3 Health Partners Inc.vs its industry peers
A metric-by-metric comparison of P3 Health Partners Inc. against SIC 8000 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PIIIEsta | $26M#3 | — | — | 0.0x#2 | -2.8%#6 | -8.9%#7 | -18.5%#1 | — | — | — | 2.9%#1 | — |
| VSEE | $3M#4 | — | — | 0.2x#4 | 40.3%#3 | 74.5%#3 | -65.6%#4 | — | — | 4#1 | -92.8%#5 | — |
| ATPC | $2M#5 | — | 0.1x#1 | 1.5x#5 | 15.2%#5 | 7.7%#5 | -213.7%#6 | -10.3%#1 | — | — | -96.4%#6 | — |
| VSEEW | $1M#6 | — | — | 0.1x#3 | 40.3%#3 | 74.5%#3 | -65.6%#4 | — | — | 4#1 | -31.1%#3 | — |
| ALPS | $66M#1 | — | — | — | — | — | — | — | — | — | — | — |
| EUDA | $31M#2 | — | — | 4.6x#6 | 70.0%#1 | 81.9%#1 | -36.3%#2 | — | — | — | -22.8%#2 | — |
| EUDAW | $55388#7 | — | — | 0.0x#1 | 70.0%#1 | 81.9%#1 | -36.3%#2 | — | — | — | -73.0%#4 | — |
| NPLY | — | — | — | — | — | -2.0%#6 | -260.6%#7 | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 8000). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice